Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population

References

• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association., xxvii, 886
   Google Scholar
• Breakefield XO, Giller EL, Jr, Nurnberger JI, Jr, Castiglione CM, Buchsbaum MS, Gershon ES. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res 1980; 2: 307–314
   PubMedGoogle Scholar
• Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578–580
   PubMed Web of Science ®Google Scholar
• Camarena B, Rinetti G, Cruz C, Gomez A, de La Fuente JR, Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 2001; 105: 279–282
   PubMed Web of Science ®Google Scholar
• Cases O, Seif I, Grimsby J, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995; 268: 1763–1766
   PubMed Web of Science ®Google Scholar
• Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am J Med Genet 2002; 114: 380–390
   PubMed Web of Science ®Google Scholar
• Deckert J, Catalano M, Syagailo YV, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999; 8: 621–624
   PubMed Web of Science ®Google Scholar
• Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 1999; 105: 542–551
   PubMed Web of Science ®Google Scholar
• Eley TC, Liang H, Plomin R, et al. Parental familial vulnerability, family environment, and their interactions as predictors of depressive symptoms in adolescents. J Am Acad Child Adolesc Psychiatry 2004a; 43: 298–306
   PubMed Web of Science ®Google Scholar
• Eley TC, Sugden K, Corsico A, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004b; 9: 908–915
   PubMed Web of Science ®Google Scholar
• Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837–844
   PubMed Web of Science ®Google Scholar
• Erdfelder E, Faul F, Buchner A. GPOWER: A general power analysis program. Behav Res Methods Instruments Computers 1996; 28: 1–11
   Google Scholar
• Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berlin) 2002; 160: 271–282
   PubMed Web of Science ®Google Scholar
• Gutierrez B, Arias B, Gasto C, et al. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet 2004; 14: 203–208
   Google Scholar
• Hotamisligil GS, Breakefield XO. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991; 49: 383–392
   PubMed Web of Science ®Google Scholar
• Huang SY, Lin WW, Ko HC, et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res 2004; 28: 374–384
   PubMed Web of Science ®Google Scholar
• Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 2000; 34: 239–244
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 2003; 289: 3095–3105
   PubMed Web of Science ®Google Scholar
• Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry 2006; 163: 109–114
   PubMed Web of Science ®Google Scholar
• Kidd KK. Associations of disease with genetic markers: deja vu all over again. Am J Med Genet 1993; 48: 71–73
   PubMed Web of Science ®Google Scholar
• Kunugi H, Ishida S, Kato T, et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999; 4: 393–395
   PubMed Web of Science ®Google Scholar
• Lin S, Jiang S, Wu X, et al. Association analysis between mood disorder and monoamine oxidase gene. Am J Med Genet 2000; 96: 12–14
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Stevens DE, Fenton B, et al. Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med 1998; 28: 773–788
   PubMed Web of Science ®Google Scholar
• Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006; 63: 1209–1216
   PubMed Web of Science ®Google Scholar
• Rao, DC, Province, MA. 2001. Genetic dissection of complex traits. San Diego, CA: Academic Press. xxi, 583
   Google Scholar
• Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103: 273–279
   PubMed Web of Science ®Google Scholar
• Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122: 509–522
   PubMed Web of Science ®Google Scholar
• Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science 1967; 156: 21–37
   PubMed Web of Science ®Google Scholar
• Schulze TG, Muller DJ, Krauss H, et al. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000; 96: 801–803
   PubMed Web of Science ®Google Scholar
• Shih JC. Molecular basis of human MAO A and B. Neuropsychopharmacology 1991; 4: 1–7
   PubMed Web of Science ®Google Scholar
• Silberg J, Rutter M, Neale M, Eaves L. Genetic moderation of environmental risk for depression and anxiety in adolescent girls. Br J Psychiatry 2001; 179: 116–121
   PubMed Web of Science ®Google Scholar
• Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004; 29: 2035–2045
   PubMed Web of Science ®Google Scholar
• Syagailo YV, Stober G, Grassle M, et al. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet 2001; 105: 168–171
   PubMed Web of Science ®Google Scholar
• von Knorring L, Perris C, Oreland L, Eisemann M, Holmgren S, Perris H. Morbidity risk for psychiatric disorders in families of probands with affective disorders divided according to levels of platelet MAO activity. Psychiatry Res 1985; 15: 271–279
   PubMedGoogle Scholar
• Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC, Yang CW. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 2005; 30: 1719–1723
   PubMed Web of Science ®Google Scholar
• Zhao JH, Sham PC. Faster haplotype frequency estimation using unrelated subjects. Hum Hered 2002; 53: 36–41
   PubMed Web of Science ®Google Scholar
• Zhu QS, Grimsby J, Chen K, Shih JC. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 1992; 12: 4437–4446
   PubMedGoogle Scholar